TOPLINE: Adjuvant cisplatin-gemcitabine significantly improves progression-free survival (PFS) over standard cisplatin-fluorouracil in N2-3 nasopharyngeal carcinoma. METHODOLOGY: The study included patients

In a recent study published in The Lancet Child & Adolescent Health Journal, researchers examined the incidence rates of eating disorders

As the demand for documentary films skyrockets, physicians are using the visual medium to raise awareness about healthcare issues, improve

Explaining why wait times can be so lengthy in the emergency room, a new study by UC San Francisco reports

The future is digital. Nowadays, it’s hard to find something that has not been computerized. Stores have replaced cashiers with

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate

Sarah de Lagarde slipped down a gap between her Tube carriage and the platform.The mum of two’s right arm and

Urgent warning to houmous lovers as popular brand sold in Tesco is recalled over fears it may contain PLASTIC A

Infants born with Down syndrome, the genetic condition caused by an extra copy of chromosome 21, or trisomy 21, are

A study by Assistant Professor KYAN Akira (Department of Social Epidemiology, Graduate School of Medicine and School of Public Health,